Discover. Connect. Capitalize.

Speakers Bureau View

70 Profile Views - 83 Presentation Views

Lexie Shannon Holliday
ASSOCIATE PROFESSOR

University of Florida

Connect

Bis-enoxacin: Development of a new drug for osteoporosis and bone cancer
Audience: Adults
Description: Development of new therapeutic agents has until recently relied on luck, or brute force (testing hundreds of thousands of molecules to find one that works). Now supercomputer-based computational chemistry has reached sufficent levels of sophistication to allow rational drug design and development.

In this presentation, I will decribe studies in my laboratory, which led to the identification of a new and better anti-resorptive for the treatment of osteoporosis and bone cancer. This is an example of what can be done in the area of rational drug design.

Keywords: Bone Disease
Cancer
Cell Biology
Computers
Molecular biology
Duration: 1 hour or less
Fee: Expenses Only
Comments: I would be happy to accept an honorarium if one is provided.

© 1999-2017, State of Florida